Registry of Patients With Hypophosphatasia
Public ClinicalTrials.gov record NCT02306720. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Observational, Longitudinal, Prospective, Long-Term Registry Of Patients With Hypophosphatasia (HPP)
Study identification
- NCT ID
- NCT02306720
- Recruitment status
- Enrolling by invitation
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Alexion Pharmaceuticals, Inc.
- Industry
- Enrollment
- 1,571 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 19, 2015
- Primary completion
- Dec 30, 2031
- Completion
- Dec 30, 2031
- Last update posted
- Feb 26, 2026
2015 – 2031
United States locations
- U.S. sites
- 20
- U.S. states
- 17
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Centennial | Colorado | 80112 | — |
| Research Site | Hartford | Connecticut | 06106 | — |
| Research Site | Tampa | Florida | 33606 | — |
| Research Site | Decatur | Georgia | 30033 | — |
| Research Site | Baltimore | Maryland | 21287 | — |
| Research Site | Boston | Massachusetts | 02111 | — |
| Research Site | Boston | Massachusetts | 02115 | — |
| Research Site | Minneapolis | Minnesota | 55454 | — |
| Research Site | Kansas City | Missouri | 64108 | — |
| Research Site | St Louis | Missouri | 63110 | — |
| Research Site | Hackensack | New Jersey | 07601 | — |
| Research Site | Mineola | New York | 11501 | — |
| Research Site | Durham | North Carolina | 27710 | — |
| Research Site | Cincinnati | Ohio | 45229 | — |
| Research Site | Columbus | Ohio | 43205 | — |
| Research Site | Pittsburgh | Pennsylvania | 15224 | — |
| Research Site | Nashville | Tennessee | 37212 | — |
| Research Site | Salt Lake City | Utah | 84112 | — |
| Research Site | Charlottesville | Virginia | 22903 | — |
| Research Site | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 44 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02306720, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 26, 2026 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02306720 live on ClinicalTrials.gov.